When the first injectable medicines for lowering cholesterol were launched last year, Wall Street was looking for blockbuster sales. Instead, the products have, so far, been a disappointment. The price tags are high and some patients still resist injections….MOREhttps://www.statnews.com/pharmalot/2016/04/07/cholesterol-statin-heart-atack/